Royalty Pharma plc Increase (Decrease) in Other Noncurrent Assets
Royalty Pharma plc (RPRX) reported Increase (Decrease) in Other Noncurrent Assets of $294.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-05
- Royalty Pharma plc increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $613.00K.
- Royalty Pharma plc increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$319.00K.
- Royalty Pharma plc increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $107.00K.
- Royalty Pharma plc increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$2.00K.
- Royalty Pharma plc increase (decrease) in other noncurrent assets for fiscal 2025 was -$276.00K.
- Royalty Pharma plc increase (decrease) in other noncurrent assets for fiscal 2024 was $0.00.
- Royalty Pharma plc increase (decrease) in other noncurrent assets for fiscal 2023 was $0.00.
- Royalty Pharma plc increase (decrease) in other noncurrent assets for fiscal 2020 was -$45.26M, a 199.19% decline from fiscal 2019.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $613.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $294.00K 10-Q · filed 2026-08-05 | $401.00K derived: sum of 3 quarters · filed 2026-08-05 | $399.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$319.00K 10-Q · filed 2026-05-06 | -$212.00K derived: sum of 2 quarters · filed 2026-05-06 | -$214.00K derived: sum of 3 quarters · filed 2026-05-06 | -$595.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $105.00K derived: sum of 2 quarters · filed 2026-02-11 | -$276.00K derived: sum of 3 quarters · filed 2026-08-05 | -$276.00K 10-K · filed 2026-02-11 |
| 2025-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$383.00K derived: sum of 2 quarters · filed 2026-08-05 | -$383.00K 10-Q · filed 2025-11-05 | -$383.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$381.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$381.00K 10-Q · filed 2026-08-05 | -$381.00K derived: sum of 3 quarters · filed 2026-08-05 | -$381.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | $0.00 derived: sum of 3 quarters · filed 2026-05-06 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $0.00 derived: sum of 2 quarters · filed 2026-02-11 | $0.00 10-K · filed 2026-02-11 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-06 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-11 | |||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $0.00 10-Q · filed 2021-08-11 | -$494.00K derived: sum of 3 quarters · filed 2021-08-11 | $371.00K derived: sum of 4 quarters · filed 2021-08-11 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-11 | -$494.00K derived: sum of 2 quarters · filed 2021-05-11 | $371.00K derived: sum of 3 quarters · filed 2021-05-11 | -$257.00K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-12-31 | -$494.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $371.00K derived: sum of 2 quarters · filed 2021-02-24 | -$257.00K derived: sum of 3 quarters · filed 2021-08-11 | -$45.26M 10-K · filed 2021-02-24 |
| 2020-09-30 | $865.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $237.00K derived: sum of 2 quarters · filed 2021-08-11 | -$44.77M 10-Q · filed 2020-11-12 | -$44.62M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-06-30 | -$628.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$45.63M 10-Q · filed 2021-08-11 | -$45.48M derived: sum of 3 quarters · filed 2021-08-11 | -$26.35M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | -$45.01M 10-Q · filed 2021-05-11 | -$44.85M derived: sum of 2 quarters · filed 2021-05-11 | -$25.72M derived: sum of 3 quarters · filed 2021-05-11 | |
| 2019-12-31 | $154.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $19.28M derived: sum of 2 quarters · filed 2021-02-24 | $45.63M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $19.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $45.48M 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $26.35M 10-Q · filed 2020-08-12 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |